Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Xerosis Treatment Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The xerosis treatment market size has experienced significant expansion in recent years. It is projected to increase from $9.4 billion in 2025 to $9.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.3%. The market’s historical growth can be ascribed to several factors, including the limited availability of specialized xerosis treatments, a rising prevalence of dry skin conditions, the growth of hospital and clinic skincare programs, a continued reliance on traditional medications, and insufficient consumer awareness regarding advanced moisturizers.
The xerosis treatment market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $12.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This forecasted growth is primarily driven by factors such as the creation of advanced emollients and humectants, the broadening scope of dermatology and homecare environments, the expanding elderly and young populations, the growing preference for products addressing multiple symptoms, and the incorporation of digital skincare monitoring technologies. Key trends during this period are characterized by an escalating demand for moisturizers and emollients, a surge in at-home skincare remedies, a heightened understanding of skin hydration and maintenance, the proliferation of fragrance-free and sensitive skin product options, and the integration of items offering relief for multiple symptoms.
Get A Free Sample Report With In-Depth Market Insights:
Xerosis Treatment Market Industry Drivers: What’s Behind The Revenue Growth?
The escalating healthcare expenditure is set to bolster the growth of the xerosis treatment market in the coming years. Healthcare expenditure refers to the aggregate financial resources allocated to health services, covering prevention, diagnosis, treatment, and disease management by individuals, governments, and organizations. The progress in medical technology is pushing up these costs, as developing, implementing, and maintaining patient care with newer diagnostic tools and treatments often entails significant expenses. Higher healthcare spending improves access to dermatological care, enabling timely diagnosis and continuous management of xerosis through professional guidance and sophisticated treatment alternatives. For example, in May 2024, the Office for National Statistics, a UK-based government agency, indicated that total healthcare spending saw a rise of 5.6% in 2023, with long-term health and social care expenditure increasing by 2.8% in real terms in 2022. Thus, the expansion of healthcare expenditure is a crucial catalyst for the xerosis treatment market. The increasing prevalence of chronic skin conditions is anticipated to drive the expansion of the xerosis treatment market. Chronic skin conditions are persistent dermatological ailments that can last for months or even years, frequently requiring ongoing management and presenting symptoms such as itching, inflammation, or skin lesions. The rising occurrence of these conditions is primarily attributable to heightened exposure to environmental pollutants, which initiate inflammation and weaken the skin’s natural barrier. Xerosis treatment aids in managing chronic skin conditions by restoring skin hydration and fortifying the skin barrier, thereby reducing dryness and irritation while enhancing overall skin health. For instance, in 2023, according to the American Academy of Dermatology, a US-based non-profit organization, acne stands as the most common skin condition in the United States, affecting up to 50 million Americans annually. Consequently, the escalating prevalence of chronic skin conditions is a significant contributor to the growth of the xerosis treatment market.
Xerosis Treatment Market Segment Analysis And Revenue Potential
The xerosis treatment market covered in this report is segmented –
1) By Type: Medication, Personal Care Products
2) By Form: Tablets, Lotion, Cream, Ointment, Shower Forms, Other Forms
3) By Symptoms: Roughness, Tightness, Itching, Flaky Skin
4) By End Users: Hospitals, Clinics, Homecare Settings, Other End Users
Subsegments:
1) By Medication: Topical Corticosteroids, Oral Antihistamines, Immunomodulators, Antibacterial Agents, Antifungal Agents
2) By Personal Care Products: Moisturizers, Emollients, Humectants, Bath Additives, Cleansers
#Xerosis Treatment Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the xerosis treatment market are concentrating on developing technological advancements, such as dexpanthenol, to improve skin hydration and repair. Dexpanthenol, a derivative of pantothenic acid (vitamin B5), assists in moisturizing and repairing the skin. It readily penetrates the skin, promoting healing and regeneration. For instance, in October 2024, Bayer, a Germany-based domestic pharmaceutical and biotechnology company, introduced Bepanthen in India. This product aims to enhance skin hydration and support the healing of dry or damaged skin. Bayer’s launch of Bepanthen in India underscored its focus on addressing widespread dry skin, which affects nearly half of the population. The product is formulated to provide deep hydration, support skin barrier repair, and promote natural skin regeneration, making it suitable for daily skincare needs.
Xerosis Treatment Market Leading Companies And Competitive Benchmarking
Major companies operating in the xerosis treatment market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Unilever PLC, Bayer AG, Sanofi S.A., L’Oréal S.A., GlaxoSmithKline plc, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Galderma S.A., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, Arcutis Biotherapeutics Inc., Neutrogena, Aveeno, CeraVe, La Roche-Posay, Nivea, Cetaphil.
View The Full Xerosis Treatment Market Report:
Xerosis Treatment Market Largest Region By Revenue And Market Share
North America was the largest region in the xerosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
